GLP-3R
Metabolic · 20 mg fill · Research Peptide
A triple GIP, GLP-1 and glucagon receptor agonist, investigated in multi-receptor incretin signaling research.
Overview
GLP-3 is an investigational synthetic peptide studied as a triple agonist at the GIP, GLP-1 and glucagon receptors. It is not approved by any regulatory agency for any indication. Supplied lyophilized for in-vitro research use.
Specifications
- Composition
- Triple GIP/GLP-1/glucagon receptor agonist (investigational, lipidated peptide)
- Form
- Lyophilized powder
- Vial Size
- 20 mg
- Purity
- Stated on the lot COA
- Reconstitution
- Bacteriostatic water
- Storage
- Room temperature · protect from light
- Documentation
- Batch-specific COA
Research use
- Triple-agonist receptor-binding assays
- GCGR, GIPR and GLP-1R signaling comparison
- Structural and receptor-conformation studies
- Comparative incretin-analog research
For research use only. This product is intended for laboratory and educational research purposes only. It is not made, labeled or sold as a drug, supplement or medical device, and it is not for human or veterinary consumption, diagnosis, treatment or cure of any condition. No dosing information is provided or implied. The molecule in this product is also the medicinal ingredient of a drug that has been authorized, or is under clinical investigation, in Canada or the United States; this product is not that drug, carries no drug identification number or marketing authorization, and is supplied solely for in vitro research.
Add to orderOpens it in the catalog so you can add it to your order.